Filter posts

Clearing Another Hurdle on the Pathway to Biosimilars

The House Energy and Commerce Committee, by a vote of 47 to 11, overwhelmingly adopted …

Patient groups join call for data protection

Biomedical innovation is not only key to our industry‚Äôs future, but more importantly, continued medical …

Victory on Biosimilars in Senate HELP Committee - But Still a Long Way from the Finish Line

Last evening the Senate Health, Education, Labor and Pensions (HELP) Committee adopted an amendment to …

The Washington Post: Special section on biotechnology

As part of our public education/industry branding campaign, BIO sponsored a special section on biotechnology …

Health Reform Debate Heats Up and Slows Down

The health reform debate is heating up and, in at least one respect, slowing down …

Already Looking Ahead to BIO 2010 in Chicago

The whirlwind of the BIO 2009 International Convention has come to a close. For the …

Podcast: Jim Greenwood Gives State of the Industry Address at BIO 2009 in Atlanta

My fellow biotech industry workers… Jim Greenwood told the 12,000 to 15,000 attendees of the …

From Jim Greenwood: Things are humming in Atlanta

I arrived Thursday to begin the pre-conference media interviews and to speak at some events …

Jim Greenwood and Andrew Young on Fox Business: The Future of Biotechnology

Jim Greenwood and Andrew Young appear on Fox Business to discuss the future of biotechnology.

From Jim Greenwood: Heading to Atlanta

With only a few days to go until we cut the ribbon for the 2009 …